BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20736974)

  • 1. Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.
    European Society of Human Genetics
    Eur J Hum Genet; 2010 Dec; 18(12):1271-3. PubMed ID: 20736974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors.
    Borry P; Howard HC; Sénécal K; Avard D
    Fam Cancer; 2010 Mar; 9(1):51-9. PubMed ID: 19488835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.
    Mathews R; Hall W; Carter A
    Addiction; 2012 Dec; 107(12):2069-74. PubMed ID: 22510165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations.
    Borry P; Evers-Kiebooms G; Cornel MC; Clarke A; Dierickx K;
    Eur J Hum Genet; 2009 Jun; 17(6):711-9. PubMed ID: 19277061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation.
    Vrecar I; Peterlin B; Teran N; Lovrecic L
    Biochem Med (Zagreb); 2015; 25(1):84-9. PubMed ID: 25672471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legislation on direct-to-consumer genetic testing in seven European countries.
    Borry P; van Hellemondt RE; Sprumont D; Jales CF; Rial-Sebbag E; Spranger TM; Curren L; Kaye J; Nys H; Howard H
    Eur J Hum Genet; 2012 Jul; 20(7):715-21. PubMed ID: 22274578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.
    Sanfilippo PG; Kearns LS; Wright P; Mackey DA; Hewitt AW
    Clin Exp Ophthalmol; 2015 Aug; 43(6):578-90. PubMed ID: 25676199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer online genetic testing and the four principles: an analysis of the ethical issues.
    Wasson K; Cook ED; Helzlsouer K
    Ethics Med; 2006; 22(2):83-91. PubMed ID: 17115513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.
    Schaper M; Schicktanz S
    BMC Med Ethics; 2018 Jun; 19(1):56. PubMed ID: 29871685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECONCEPTUALIZING CONSENT FOR DIRECT-TO-CONSUMER HEALTH SERVICES.
    Spector-Bagdady K
    Am J Law Med; 2015; 41(4):568-616. PubMed ID: 26863850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests.
    Wade CH; Wilfond BS
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):284-92, discussion 293. PubMed ID: 17068807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations of the European society of human genetics on genetic testing for common disorders.
    Field A; Baxter K; Terry SF
    Genet Test Mol Biomarkers; 2011 May; 15(5):291-2. PubMed ID: 21561286
    [No Abstract]   [Full Text] [Related]  

  • 14. Mental disorders and genetics: the ethical context: conclusions and recommendations.
    United Kingdom. Nuffield Council on Bioethics
    J Int Bioethique; 2001 Jun; 12(2):89-92. PubMed ID: 12747351
    [No Abstract]   [Full Text] [Related]  

  • 15. National Ethical Consultative Committee for the Life and Health Sciences in France issues opinion entitled "Genetics and medicine: from prediction to prevention.
    Int Dig Health Legis; 1996; 47(2):263-5. PubMed ID: 11655202
    [No Abstract]   [Full Text] [Related]  

  • 16. "I would rather have it done by a doctor"-laypeople's perceptions of direct-to-consumer genetic testing (DTC GT) and its ethical implications.
    Schaper M; Wöhlke S; Schicktanz S
    Med Health Care Philos; 2019 Mar; 22(1):31-40. PubMed ID: 29705970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patenting and licensing in genetic testing.
    ESHG Working Party on Patenting and Licensing
    Eur J Hum Genet; 2008 Apr; 16(4):405-11. PubMed ID: 18354424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information Provided to Consumers about Direct-to-Consumer Nutrigenetic Testing.
    De S; Pietilä AM; Iso-Touru T; Hopia A; Tahvonen R; Vähäkangas K
    Public Health Genomics; 2019; 22(5-6):162-173. PubMed ID: 31779000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendation No. R(92)3 of the Committee of Ministers to member states on genetic testing and screening for health care purposes.
    Council of Europe
    J Int Bioethique; 1992 Dec; 3(4):255-7. PubMed ID: 11651417
    [No Abstract]   [Full Text] [Related]  

  • 20. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
    Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
    J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.